• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Chase Corporation Announces Fiscal Third Quarter 2023 Results

    7/6/23 5:14:00 PM ET
    $CCF
    Building Products
    Consumer Discretionary
    Get the next $CCF alert in real time by email

    Quarterly Revenue Increased 20.3% Year-Over-Year

    Company-Wide Inventory Reduction Plan Well Underway

    Disciplined Capital Allocation Drove Further Debt Payments

    Chase Corporation (NYSE:CCF), a global specialty chemicals company that is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors, today announced financial results for the third fiscal quarter ended May 31, 2023.

    Fiscal Third Quarter and Year-to-Date Financial and Recent Operational Highlights

    • Total Revenue grew 20.3% to $106.6 million, and 27.9% to $303.8 million, in the third quarter and first nine-months of fiscal 2023, respectively
    • Gross Margin of 37.7% (40.2% excluding NuCera) in the third quarter of fiscal 2023, compared to 38.6% in the third quarter of fiscal 2022; Gross Margin of 36.5% (39.6% excluding NuCera) in the first nine-months of fiscal 2023, compared to 37.4% in the first-nine months of fiscal 2022
    • Net Income was $12.1 million, or $1.27 per diluted share, compared to $15.5 million, or $1.64 per diluted share in the third quarter of fiscal 2022, with the reduction primarily due to additional $3.1 million ($0.24 per diluted share) incremental amortization expense related to the NuCera business
    • Free Cash Flow was $21.4 million and $36.1 million in the third quarter and first-nine months of fiscal 2023, respectively, compared to Free Cash Flow of $10.2 million and $17.2 million in the third quarter and first-nine months of fiscal 2022, respectively
    • Adjusted EBITDA grew 15.2% to $26.3 million and 28.2% to $73.5 million in the third quarter and first-nine months of fiscal 2023, respectively, compared to Adjusted EBITDA of $22.8 million and $57.3 million in the third quarter and first-nine months of fiscal 2022, respectively

    Adam P. Chase, President and Chief Executive Officer of Chase Corporation, said, "We are pleased by Chase's continued operational excellence in the fiscal third quarter, including continued progress against our key growth initiatives and inventory reduction efforts. Increased inorganic growth from our NuCera business, coupled with tailwinds from our now fully realized price increases, drove much of our year-over-year revenue improvement. Our Adhesives, Sealants and Additives, and Industrial Tapes segments led sales in the quarter, predominately due to continued inorganic revenue from our NuCera business and increased demand seen in our electronic and industrial coatings product lines, as well as our specialty products and pulling and detection product lines. Conversely, our Corrosion Protection and Waterproofing segment experienced a moderate decline due to lower sales volume and customer destocking over the comparative period, tempering the quarter's results."

    Mr. Chase added, "Although we enjoyed revenue strength in the period, there was a slight decline in gross margin in the third fiscal quarter and year-to-date period. This stepdown can be attributed to lower than historical gross margin from the NuCera business, as well as some impact from customer destocking and inventory reduction initiatives. As we continue integrating NuCera, our focus remains on establishing further operational efficiencies. However, excluding NuCera, Chase's margin profile surpassed the prior year's margins, demonstrating the Company's continued commitment to financial discipline."

    Mr. Chase continued, "We are actively executing our previously announced inventory reduction plan, thus enhancing our cash flow and positioning the business to make additional payments toward our Long-Term Debt. Additionally, the Company made strides toward its ongoing consolidation and optimization initiative, having moved out of NuCera's Woodlands, TX facility and subleasing the office in the third quarter. Chase continues to prioritize its proven growth strategy of maintaining financial flexibility, cost management, and minimizing its corporate footprint. We continue to evaluate additional opportunities to improve our profitability profile and further integrate the NuCera business."

    Mr. Chase concluded, "Our team is excited for the remainder of fiscal year 2023 and is prepared to continue growing our Company both organically and inorganically, as well as continued synergies. We would like to thank our Chase employees for their continued dedication to our business, customers, and operational excellence."

    Michael J. Bourque, Chase Corporation's Treasurer and Chief Financial Officer, stated, "We are keenly focused on the integration of NuCera, and are pleased with continued demand for our Adhesives, Sealants and Additives and Industrial Tapes segments in the fiscal third quarter. Our inventory reduction initiative coupled with a moderated macro environment created an attractive opportunity for Chase to execute $50 million in payments in the nine-month period of fiscal 2023 on our revolver debt, increasing debt availability to $170 million. Additionally, Chase made payments of $10 million during the month of June on our revolving debt facility, reducing our outstanding debt balance to $120 million and increasing our debt availability to $180 million. It is our intent to continue accelerating debt paydown as much as possible in future quarters. Our balance sheet remains healthy with $43 million of cash and a current ratio of 5.2 as of May 31, 2023. Chase is well positioned to maintain financial flexibility, continue to pay down debt, and deliver for our dedicated customers."

    Segment Results

    Adhesives, Sealants and Additives

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended May 31,

     

    Nine Months Ended May 31,

     

     

    2023

     

    2022

     

    2023

     

    2022

    Revenue

     

    $

    55,083

     

    $

    36,771

     

    $

    159,370

     

    $

    99,600

    Cost of products and services sold

     

     

    33,620

     

     

    21,073

     

     

    100,621

     

     

    59,828

    Gross Margin

     

    $

    21,463

     

    $

    15,698

     

    $

    58,749

     

    $

    39,772

    Gross Margin %

     

     

    39%

     

     

    43%

     

     

    37%

     

     

    40%

    Revenue for our Adhesives, Sealants and Additives segment increased in the third quarter and year-to-date period against the comparable prior year periods. The segment revenue increased $18.3 million, or 50% and $59.8 million, or 60% in the current quarter and year-to-date period, respectively. The third quarter and year-to-date revenue increase was predominately due to the inorganic growth from our NuCera business acquired on the first day of fiscal 2023, totaling $16.2 million and $53.9 million in the third quarter and year-to-date period, respectively. The remaining revenue increase for the third fiscal quarter and first nine-month period of the fiscal year was primarily attributed to sales price increases realized over the comparable prior periods and increased demand for our world-wide focused electronic and industrial coatings product line, totaling $5.7 million and $9.1 million in the third quarter and nine-month period of fiscal 2023. Partially offsetting this increase in revenue in the third fiscal quarter and year-to-date period was reduction in revenue in our organic functional additives product line due to decreased customer demand in North America over the comparable prior fiscal quarter, totaling $3.6 million and $3.2 million in the current fiscal quarter and year-to-date period, respectively.

    Industrial Tapes

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended May 31,

     

    Nine Months Ended May 31,

     

     

    2023

     

    2022

     

    2023

     

    2022

    Revenue

     

    $

    40,927

     

    $

    38,329

     

    $

    116,987

     

    $

    104,420

    Cost of products and services sold

     

     

    26,609

     

     

    25,836

     

     

    75,805

     

     

    69,845

    Gross Margin

     

    $

    14,318

     

    $

    12,493

     

    $

    41,182

     

    $

    34,575

    Gross Margin %

     

     

    35%

     

     

    33%

     

     

    35%

     

     

    33%

    Revenue for our Industrial Tapes segment increased in the third quarter and year-to-date period over the comparable prior year periods. The segment revenue increased $2.6 million, or 7% and $12.6 million, or 12% in the current quarter and year-to-date period, respectively. Sales price increases realized over the prior year periods and increased demand for our North American-focused specialty products and pulling and detection product line, which increased by $4.1 million and $6.6 million, respectively, positively impacted revenue for the third quarter and year-to-date period. In addition, our North American-focused cable materials product line continues to experience a year-to-date increase in revenue over the comparable year-to-date period, totaling $7.8 million. Partially offsetting the increase in third quarter revenue was a decrease in demand in our cable materials product line over the comparable prior year quarter due to increased demand in the previous year attributed to customer inventory increase initiatives in reaction to supply chain shortages, totaling a decrease of $467,000. Also tempering the overall increase in revenue for the segment was a third quarter and year-to-date reduction in sales volume from our Asia-focused electronic materials product line, totaling $991,000 and $1.8 million in the current quarter and year-to-date period, respectively.

    Corrosion Protection and Waterproofing

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended May 31,

     

    Nine Months Ended May 31,

     

     

    2023

     

    2022

     

    2023

     

    2022

    Revenue

     

    $

    10,635

     

    $

    13,519

     

    $

    27,461

     

    $

    33,562

    Cost of products and services sold

     

     

    6,208

     

     

    7,529

     

     

    16,632

     

     

    18,957

    Gross Margin

     

    $

    4,427

     

    $

    5,990

     

    $

    10,829

     

    $

    14,605

    Gross Margin %

     

     

    42%

     

     

    44%

     

     

    39%

     

     

    44%

    Revenue in the Company's Corrosion Protection and Waterproofing segment decreased in the third quarter and year-to-date period over the comparable prior year periods. The segment revenue decreased $2.9 million, or 21% and $6.1 million, or 18% in the current quarter and year-to-date period, respectively. Negatively impacting sales for the segment was a reduction in sales volume for our building envelope product line over the comparable prior year periods attributed to customer destocking, totaling $600,000 and $3.2 million in the third quarter and year-to-date periods, respectively. Also, negatively impacting sales for the segment was a reduction in sales volume for our coating and linings product line in the third quarter and year-to-date period primarily attributed to delayed customer projects due to the extended rainy season in the west coast of North America. This was coupled with increased prior year demand due to customer inventory increase initiatives in reaction to supply chain shortages, totaling $550,000 and $1.5 million in the current quarter and year-to-date period. Additionally, negatively impacting segment sales was our pipeline coatings product line attributed to delayed projects in the Middle East market over the prior comparable quarter and year-to-date period coupled with customer destocking initiatives in North American oil and gas markets, totaling $1.6 million and $1.6 million in the current quarter and year-to-date period, respectively. Furthermore, negatively impacting segment sales was decreased demand in our bridge and highway product line for the third quarter due to delayed bridge and highway projects in North America, totaling $103,000. However, our bridge and highway product line is experiencing an increase in revenue for the year-to-date period, totaling $158,000.

    About Chase Corporation

    Chase Corporation, a global specialty chemicals company that was founded in 1946, is a leading manufacturer of protective materials for high-reliability applications throughout the world. More information can be found on our website https://chasecorp.com/

    Use of Non-GAAP Financial Measures

    The Company has used non-GAAP financial measures in this press release. Adjusted net income, Adjusted diluted EPS, EBITDA, Adjusted EBITDA and Free cash flow are non-GAAP financial measures. The Company believes that Adjusted net income, Adjusted diluted EPS, EBITDA, Adjusted EBITDA and Free cash flow are useful performance measures as they are used by its executive management team to measure operating performance, to allocate resources to enhance the financial performance of its business, to evaluate the effectiveness of its business strategies and to communicate with its board of directors and investors concerning its financial performance. The Company believes Adjusted net income, Adjusted diluted EPS, EBITDA, Adjusted EBITDA and Free cash flow are commonly used by financial analysts and others in the industries in which the Company operates, and thus provide useful information to investors. However, Chase's calculation of Adjusted net income, Adjusted diluted EPS, EBITDA, Adjusted EBITDA and Free cash flow may not be comparable to similarly-titled measures published by others. Non-GAAP financial measures should be considered in addition to, and not as an alternative to, the Company's reported results prepared in accordance with GAAP. This press release provides reconciliations from the most directly comparable financial measure presented in accordance with U.S. GAAP to each non-GAAP financial measure.

    Cautionary Note Concerning Forward-Looking Statements

    Certain statements in this press release are forward-looking. These may be identified by the use of forward-looking words or phrases including, but not limited to, "believe," "expect," "anticipate," "should," "planned," "estimated" and "potential." These forward-looking statements are based on Chase Corporation's current expectations. The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for such forward-looking statements. To comply with the terms of the safe harbor, the Company cautions investors that any forward-looking statements made by the Company are not guarantees of future performance and that a variety of factors could cause the Company's actual results and experience to differ materially from the anticipated results or other expectations expressed in the Company's forward-looking statements. The risks and uncertainties which may affect the operations, performance, development and results of the Company's business include, but are not limited to, the following: uncertainties relating to economic conditions; uncertainties relating to customer plans and commitments; the pricing and availability of equipment, materials and inventories; technological developments; performance issues with suppliers and subcontractors; economic growth; delays in testing of new products; the Company's ability to successfully integrate acquired operations; the effectiveness of cost-reduction plans; rapid technology changes; the highly competitive environment in which the Company operates; as well as expected impact of the coronavirus disease (COVID-19) pandemic on the Company's businesses. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. The Company does not assume any obligation to update or revise any forward-looking statement made in this release or that may from time to time be made by or on behalf of the Company. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with the Securities and Exchange Commission, including the risks and uncertainties identified in Part I, Item 1A - Risk Factors of the Company's Annual Report on Form 10-K for the year ended August 31, 2022.

    The following table summarizes the Company's unaudited financial results for the three and first nine months ended May 31, 2023 and 2022.

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended May 31,

     

    Nine Months Ended May 31,

    All figures in thousands, except per share figures

     

    2023

     

    2022

     

    2023

     

    2022

    Revenue

     

    $

    106,645

     

     

    $

    88,619

     

     

    $

    303,818

     

     

    $

    237,582

     

    Costs and Expenses

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of products and services sold

     

     

    66,437

     

     

     

    54,438

     

     

     

    193,058

     

     

     

    148,630

     

    Selling, general and administrative expenses

     

     

    19,189

     

     

     

    13,807

     

     

     

    59,232

     

     

     

    40,307

     

    Research and product development costs

     

     

    1,527

     

     

     

    1,186

     

     

     

    4,481

     

     

     

    3,274

     

    Operations optimization costs

     

     

    215

     

     

     

    59

     

     

     

    1,506

     

     

     

    707

     

    Acquisition-related costs

     

     

    —

     

     

     

    —

     

     

     

    29

     

     

     

    —

     

    Loss on impairment/write-off of long-term assets

     

     

    331

     

     

     

    —

     

     

     

    1,193

     

     

     

    —

     

    Loss (Gain) on contingent consideration

     

     

    129

     

     

     

    (474

    )

     

     

    563

     

     

     

    (199

    )

    Operating income

     

     

    18,817

     

     

     

    19,603

     

     

     

    43,756

     

     

     

    44,863

     

    Interest expense

     

     

    (2,361

    )

     

     

    (89

    )

     

     

    (6,886

    )

     

     

    (262

    )

    Other (expense) income

     

     

    (308

    )

     

     

    (166

    )

     

     

    (1,130

    )

     

     

    231

     

    Income before income taxes

     

     

    16,148

     

     

     

    19,348

     

     

     

    35,740

     

     

     

    44,832

     

    Income taxes

     

     

    4,056

     

     

     

    3,803

     

     

     

    8,421

     

     

     

    10,434

     

    Net income

     

    $

    12,092

     

     

    $

    15,545

     

     

    $

    27,319

     

     

    $

    34,398

     

    Net income per diluted share

     

    $

    1.27

     

     

    $

    1.64

     

     

    $

    2.87

     

     

    $

    3.62

     

    Weighted average diluted shares outstanding

     

     

    9,463

     

     

     

    9,431

     

     

     

    9,451

     

     

     

    9,435

     

    Reconciliation of net income to EBITDA and adjusted EBITDA

     

     

     

     

     

     

     

     

     

     

     

     

    Net income

     

    $

    12,092

     

     

    $

    15,545

     

     

    $

    27,319

     

     

    $

    34,398

     

    Interest expense

     

     

    2,361

     

     

     

    89

     

     

     

    6,886

     

     

     

    262

     

    Income taxes

     

     

    4,056

     

     

     

    3,803

     

     

     

    8,421

     

     

     

    10,434

     

    Depreciation expense

     

     

    2,172

     

     

     

    878

     

     

     

    6,708

     

     

     

    2,654

     

    Amortization expense

     

     

    4,941

     

     

     

    2,925

     

     

     

    18,721

     

     

     

    9,092

     

    EBITDA

     

    $

    25,622

     

     

    $

    23,240

     

     

    $

    68,055

     

     

    $

    56,840

     

    Loss (Gain) on contingent consideration

     

     

    129

     

     

     

    (474

    )

     

     

    563

     

     

     

    (199

    )

    Operations optimization costs

     

     

    215

     

     

     

    59

     

     

     

    1,506

     

     

     

    707

     

    Acquisition-related costs

     

     

    —

     

     

     

    —

     

     

     

    29

     

     

     

    —

     

    Purchase accounting adjustments

     

     

    —

     

     

     

    —

     

     

     

    2,200

     

     

     

    —

     

    Loss on impairment/write-off of long-term assets

     

     

    331

     

     

     

    —

     

     

     

    1,193

     

     

     

    —

     

    Adjusted EBITDA

     

    $

    26,297

     

     

    $

    22,825

     

     

    $

    73,546

     

     

    $

    57,348

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended May 31,

     

    Nine Months Ended May 31,

     

     

    2023

     

    2022

     

    2023

     

    2022

    Reconciliation of net income to adjusted net income

     

     

     

     

     

     

     

     

     

     

     

     

    Net income

     

    $

    12,092

     

     

    $

    15,545

     

     

    $

    27,319

     

     

    $

    34,398

     

    Stock based compensation excess tax loss (gain)

     

     

    4

     

     

     

    —

     

     

     

    (127

    )

     

     

    10

     

    Loss on contingent consideration

     

     

    129

     

     

     

    (474

    )

     

     

    563

     

     

     

    (199

    )

    Operations optimization costs

     

     

    215

     

     

     

    59

     

     

     

    1,506

     

     

     

    707

     

    Acquisition-related costs

     

     

    —

     

     

     

    —

     

     

     

    29

     

     

     

    —

     

    Purchase accounting adjustments

     

     

    —

     

     

     

    —

     

     

     

    2,200

     

     

     

    —

     

    Loss on impairment/write-off of long-term assets

     

     

    331

     

     

     

    —

     

     

     

    1,193

     

     

     

    —

     

    Income taxes *

     

     

    (142

    )

     

     

    87

     

     

     

    (1,153

    )

     

     

    (107

    )

    Adjusted net income

     

    $

    12,629

     

     

    $

    15,217

     

     

    $

    31,530

     

     

    $

    34,809

     

    Adjusted net income per diluted share (Adjusted diluted EPS)

     

    $

    1.32

     

     

    $

    1.60

     

     

    $

    3.31

     

     

    $

    3.66

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    * For the three and first nine months ended May 31, 2023 and 2022, represents the aggregate tax effect assuming a 21% tax rate for the items impacting pre-tax income, which is our effective U.S. statutory Federal tax rate for fiscal 2023 and 2022.

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended May 31,

     

    Nine Months Ended May 31,

     

     

    2023

     

    2022

     

    2023

     

    2022

    Reconciliation of cash provided by operating activities to free cash flow

     

     

     

     

     

     

     

     

     

     

     

     

    Net cash provided by operating activities

     

    $

    22,624

     

     

    $

    11,529

     

     

    $

    41,815

     

     

    $

    20,286

     

    Purchases of property, plant and equipment

     

     

    (1,269

    )

     

     

    (1,334

    )

     

     

    (5,729

    )

     

     

    (3,103

    )

    Free cash flow

     

    $

    21,355

     

     

    $

    10,195

     

     

    $

    36,086

     

     

    $

    17,183

     

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230706069030/en/

    Get the next $CCF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CCF

    DatePrice TargetRatingAnalyst
    More analyst ratings